… Patients with follicular lymphoma (FL) frequently require multiple treatments during their …
in the post-rituximab era. Also, the Follicular Lymphoma International Prognostic Index (FLIPI) …

Follicular lymphomas (FL) account for 30% of non-Hodgkin’s lymphomas (NHL). Their
evolution is heterogeneous. Some patients present with indolent forms undergoing several …

We assessed the incidence, prognostic features, and outcomes associated with transformation
of follicular lymphoma (FL) among 2652 evaluable patients prospectively enrolled in the …

… Of the 35,961 patients with follicular lymphoma included in the current study, 63% had
stage I disease, 79% were without extranodal disease, and 61% were aged >60 years. RT use …

… Even in the modern era, follicular lymphoma (FL) remains largely an incurable but treatable
disease with both standard and novel treatment modalities. Despite the abundance of …

… Follicular lymphoma (FL) is generally considered an indolent disorder. With modern day …
Their identification is the main purpose of modern day prognostic tools. In this review, we …

… Regardless of the prognostic model used, modern therapies … Follicular lymphoma is the
second most common lymphoma … -Hodgkin lymphomas (NHLs), and 70% of indolent lymphomas.…

… Follicular lymphoma is generally an indolent B cell lymphoproliferative disorder of transformed
follicular center B cells. … With the use of more modern therapies, outcomes have improved. …

… To examine the effectiveness of an initial management strategy of watchful waiting for follicular
lymphoma (FL) in clinical practice, we compared outcomes for patients diagnosed 2004–…

… (FL) is the second most common non-Hodgkin lymphoma (NHL) … lymphoma among
indolent NHL, defined as lymphomas with … and outcome of follicular lymphoma post-transformation. …